Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients

Withdrawn

• Conditions: Neoplasm Metastasis; Liver; Colorectal Neoplasms; Magnetic Resonance Imaging; Contrast Media

• Registration Number: NCT00718055
• Lead Sponsor: Copenhagen University Hospital at Herlev

Brief Summary

The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-10-04
• Study Start: 2006-11
• Study First Submitted QC: 2008-07-17
• Study First Posted: 2008-07-18
• Status Verified: 2009-02
• Last Update Submitted: 2009-02-09
• Last Update Posted: 2009-02-10

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• biopsy proved liver metastasis

Exclusion Criteria

• pacemaker, metal in the body, claustrophobia, pregnancy, age below 18 years, psychiatry patients

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Copenhagen Uni. Hospital at Herlev dept. of Radiology; 🇩🇰 Herlev, Denmark